A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation
- PMID: 24194503
- PMCID: PMC3931402
- DOI: 10.2337/db13-0573
A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation
Abstract
Obesity causes increased classical and decreased alternative macrophage activation, which in turn cause insulin resistance in target organs. Because A2B adenosine receptors (ARs) are important regulators of macrophage activation, we examined the role of A2B ARs in adipose tissue inflammation and insulin resistance. A2B AR deletion impaired glucose and lipid metabolism in mice fed chow but not a high-fat diet, which was paralleled by dysregulation of the adipokine system, and increased classical macrophage activation and inhibited alternative macrophage activation. The expression of alternative macrophage activation-specific transcriptions factors, including CCAAT/enhancer-binding protein-β, interferon regulatory factor 4, and peroxisome proliferator-activated receptor-γ, was decreased in adipose tissue of A2B AR-deficient mice. Furthermore, in in vitro studies, we found that stimulation of A2B ARs suppressed free fatty acid-induced deleterious inflammatory and metabolic activation of macrophages. Moreover, AR activation upregulated the interleukin-4-induced expression of CCAAT/enhancer-binding protein-β, interferon regulatory factor 4, and peroxisome proliferator-activated receptor-γ in macrophages. Altogether, our results indicate that therapeutic strategies targeting A2B ARs hold promise for preventing adipose tissue inflammation and insulin resistance.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3931402/bin/850fig1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3931402/bin/850fig2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3931402/bin/850fig3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3931402/bin/850fig4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3931402/bin/850fig5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3931402/bin/850fig6.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3931402/bin/850fig7.gif)
Similar articles
-
Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγ of insulin resistance induced by high-fat diet-associated obesity.Exp Cell Res. 2017 Jun 15;355(2):105-112. doi: 10.1016/j.yexcr.2017.03.060. Epub 2017 Mar 30. Exp Cell Res. 2017. PMID: 28365247
-
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.Biochim Biophys Acta. 2014 Mar;1842(3):446-62. doi: 10.1016/j.bbadis.2013.05.017. Epub 2013 May 22. Biochim Biophys Acta. 2014. PMID: 23707515 Free PMC article. Review.
-
Adenosine promotes alternative macrophage activation via A2A and A2B receptors.FASEB J. 2012 Jan;26(1):376-86. doi: 10.1096/fj.11-190934. Epub 2011 Sep 16. FASEB J. 2012. PMID: 21926236 Free PMC article.
-
Macrophages, inflammation, and insulin resistance.Annu Rev Physiol. 2010;72:219-46. doi: 10.1146/annurev-physiol-021909-135846. Annu Rev Physiol. 2010. PMID: 20148674 Review.
-
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.Nature. 2007 Jun 28;447(7148):1116-20. doi: 10.1038/nature05894. Epub 2007 May 21. Nature. 2007. PMID: 17515919 Free PMC article.
Cited by
-
A2B adenosine receptor signaling and regulation.Purinergic Signal. 2024 Jun 4. doi: 10.1007/s11302-024-10025-y. Online ahead of print. Purinergic Signal. 2024. PMID: 38833181 Review.
-
Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A2BR signaling.Respir Res. 2023 Jul 13;24(1):186. doi: 10.1186/s12931-023-02486-3. Respir Res. 2023. PMID: 37438813 Free PMC article.
-
The identification of metabolism-related subtypes and potential treatments for idiopathic pulmonary fibrosis.Front Pharmacol. 2023 May 18;14:1173961. doi: 10.3389/fphar.2023.1173961. eCollection 2023. Front Pharmacol. 2023. PMID: 37274115 Free PMC article.
-
Dual A1 and A2A adenosine receptor antagonists, methoxy substituted 2-benzylidene-1-indanone, suppresses intestinal postprandial glucose and attenuates hyperglycaemia in fructose-streptozotocin diabetic rats.BMC Endocr Disord. 2023 May 4;23(1):97. doi: 10.1186/s12902-023-01354-x. BMC Endocr Disord. 2023. PMID: 37143025 Free PMC article.
-
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression.Int J Mol Sci. 2023 Feb 23;24(5):4428. doi: 10.3390/ijms24054428. Int J Mol Sci. 2023. PMID: 36901855 Free PMC article. Review.
References
-
- Grundy SM. Use of emerging lipoprotein risk factors in assessment of cardiovascular risk. JAMA 2012;307:2540–2542 - PubMed
-
- Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012;307:491–497 - PubMed
-
- Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785–789 - PubMed
-
- Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87–91 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials